NCT07047404View on ClinicalTrials.gov

Proof of Concept Study on BP1.4979 Effect on Primary Premature Ejaculation

PHASE2RecruitingINTERVENTIONAL

Enrollment

60

Participants

Timeline

Start Date

September 15, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions

Premature (Early) Ejaculation

Interventions

DRUG

BP1.4979

selective dopamine D3 partial agonist

DRUG

Placebo

matching placebo of BP1.4979 30mg tablet

Trial Locations (1)

30029

RECRUITING

University Hospital of Nîmes, Nîmes

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Bioprojet

OTHER